🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the brain cholesterol 24S-hydroxy...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02497235
Treatments Being Tested
The main aim is to see how soticlestat tablets of different strengths work ...
Status
Completed
Location
Celerion
Start Date
2022-03-11
Trial ID
NCT05284760
Treatments Being Tested
The main aim of this study is to check how rifampin affects the way soticle...
Status
Completed
Location
Celerion
Start Date
2021-11-22
Trial ID
NCT05098041
Treatments Being Tested
The purpose of this study is to check how soticlestat impacts symptoms of D...
Status
Terminated
Location
Epilepsihospitalet Filadelfia
Start Date
2024-04-25
Trial ID
NCT06422377
Treatments Being Tested
The main aim of the study is to learn if soticlestat, when given as an add-...
Status
Completed
Location
Phoenix Childrens Hospital
Start Date
2021-10-28
Trial ID
NCT04940624
Treatments Being Tested
The purpose of this study is to investigate the effect on the frequency of ...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-08-08
Trial ID
NCT03650452
The main aim is to check the effect of a single dose of soticlestat in adul...
Status
Completed
Location
Velocity
Start Date
2021-10-29
Trial ID
NCT05098054
Treatments Being Tested
The main aim of the study is to learn if soticlestat, when given as an add-...
Status
Terminated
Location
Phoenix Childrens Hospital
Start Date
2022-03-04
Trial ID
NCT05163314
Treatments Being Tested
The purpose of this study is to investigate the effect of soticlestat (TAK-...
Status
Completed
Location
St Pancras Clinical Research
Start Date
2019-07-23
Trial ID
NCT03990649
Treatments Being Tested
The purpose of this study is to characterize the multiple-dose safety and t...
Status
Completed
Location
Xenoscience
Start Date
2017-08-17
Trial ID
NCT03166215